Skaana Management’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-73,130
Closed -$2.48K – 223
2023
Q2
$2.48K Hold
73,130
– – ﹤0.01% 157
2023
Q1
$5.08K Hold
73,130
– – ﹤0.01% 132
2022
Q4
$1.84K Hold
73,130
– – ﹤0.01% 161
2022
Q3
$16K Buy
+73,130
New +$18K 0.01% 67

Other funds holding APGNW

Skaana Management's APGNW Position: Q3 2023 in Review

Skaana Management sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 73,130 shares — an estimated $2.48K sold.

Skaana Management first reported a position in APGNW in Q3 2022 and held it in 4 quarters. The position peaked at $16K in Q3 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

  • Skaana Management reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
  • Skaana Management sold 73,130 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $2.48K.
  • Skaana Management first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2022 and held it in 4 quarters.
  • Skaana Management's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $16K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Skaana Management's 13F filing for Q3 2023, filed 14 Nov 2023.